Stay updated on AFM24 in Advanced Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 in Advanced Solid Cancers Clinical Trial page.

Latest updates to the AFM24 in Advanced Solid Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new dosage information for the drug AFM24, specifically 160 mg, 320 mg, 480 mg, and 720 mg, while significant details about the study's design and inclusion criteria have been removed.SummaryDifference21%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to AFM24 in Advanced Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 in Advanced Solid Cancers Clinical Trial page.